SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001273087-24-000012
Filing Date
2024-01-12
Accepted
2024-01-12 16:26:23
Documents
1
Group Members
ISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 VKTX_SC13GA1.htm SC 13G/A 79786
  Complete submission text file 0001273087-24-000012.txt   81662
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
MILLENNIUM MANAGEMENT LLC (Filed by) CIK: 0001273087 (see all company filings)

IRS No.: 133804139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88828 | Film No.: 24532353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)